Including updates for your frame displays and for how you administer eye drops.
Dr. Sean Ianchulev will transition to non-executive chairman of the board.
This is for the reduction of pediatric myopia progression In children ages 3-12.
(PRESS RELEASE) NEW YORK – Eyenovia Inc. announced that it has appointed Kenneth B. Lee Jr., Charles E. Mather IV and Anthony Y. Sun as independent members of its board...
It’s developing products for glaucoma and other conditions. NEW YORK — Biopharmaceutical company Eyenovia Inc. has closed on an initial public offering of 2.73 million shares...
Get the most important news and business ideas for eyecare professionals every weekday from INVISION.